This Eye-Popping Chart Of Ex-US Companies Shows Why People Are Freaking Out About 'Tax Inversions'
We keep hearing about "tax inversions."
A tax inversion is a corporate merger strategy that involves a company based in one country, say the U.S., acquires another company based somewhere else, say the U.K., and following the deal moves its tax base to enjoy a lower corporate tax rate.
This year, some notable tax inversions, or proposed tax inversions, include Minnesota-based Medtronic's $43 billion deal to acquire Covidien and move its tax base to Ireland; Illinois-based AbbVie's $53 billion deal to acquire Shire and move its tax base to Jersey, an island in the English Channel; and New York-based Pfizer's failed attempt to acquire U.K.-based AstraZeneca.
A report in The New York Times this morning said that the Obama administration is continuing to push for legislation that could retroactively strip the tax advantages achieved by companies in some of this year's deals.
And so it seems that both Congress and Wall Street have taken notice of this loophole, and one look at this chart from Goldman Sachs says it all.
Goldman Sachs
- 2 states where home prices are falling because there are too many houses and not enough buyers
- US buys 81 Soviet-era combat aircraft from Russia's ally costing on average less than $20,000 each, report says
- A couple accidentally shipped their cat in an Amazon return package. It arrived safely 6 days later, hundreds of miles away.
- BenQ Zowie XL2546X review – Monitor for the serious gamers
- 9 health benefits of drinking sugarcane juice in summer
- 10 benefits of incorporating almond oil into your daily diet
- From heart health to detoxification: 10 reasons to eat beetroot
- Why did a NASA spacecraft suddenly start talking gibberish after more than 45 years of operation? What fixed it?